eIF3a function in immunity and protection against severe sepsis by regulating B cell quantity and function through m6A modification
aDepartment of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Xiangya Hospital, Central South University, Changsha 410008, China
bInstitute of Clinical Pharmacology, Central South University, Changsha 410078, China
cEngineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Central South University, Changsha 410078, China
dNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China
eDepartment of Lymphoma & Hematology, Hunan Cancer Hospital, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China
fDepartment of Geratic Surgery, Xiangya Hospital, Central South University, Changsha 410008, China
gDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, China
hDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, China
iDepartment of Pharmacy, Hunan Traditional Chinese Medical College, Zhuzhou 412000, China
jScientific Research Office, Hunan Cancer Hospital, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, China
kDepartment of Cardiac Surgery, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences/Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming 650102, China
lCenter of Clinical Pharmacology, the Third Xiangya Hospital, Central South University, Changsha 410017, China
mDepartment of Cell and Cancer Biology, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43606, USA
* Corresponding authors.
收起